Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

Background The outcomes of immunosuppressive therapy, when added to supportive care,
in patients with IgA nephropathy are uncertain. Methods We conducted a multicenter, open …

IgA nephropathy (IgAN) is observed in subjects of any age, however perspective and
management of this disease are different between adult and pediatrician Nephrologists …

The identification of risk factors conditioning the progression of immunoglobulin (Ig) A
nephropathy (IgAN) is needed due to the variability of the outcome of this renal disease …

Background There is a need for early identification of children with immunoglobulin A
nephropathy (IgAN) at risk of progression of kidney disease. Methods Data on 261 young …

IgA nephropathy (IgAN) is a common chronic glomerular disease that, in most patients,
slowly progresses to ESRD. The immune and autoimmune responses that characterize IgAN …

Although IgA nephropathy (IgAN) is a common cause of glomerulonephritis in children, the
absence of a method to predict disease progression limits personalized risk-based treatment …

Abstract Background Henoch–Schönlein purpura (HSP) nephritis and primary IgA
nephropathy (pIgAN) present with glomerular IgA deposits, but differ with regard to clinical …

IgA nephropathy (IgAN) has variable clinical presentation and outcome. There is a need to
identify children who have the potential to progress to end stage renal disease (ESRD) …

Introduction There is a need for treatment guidelines and prognostic factor identification in
children with primary IgA nephropathy. We analyzed the causative effect of steroids and the …